Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher Scientific shares fell 2.1% to $625.98 on Friday, reversing after a 52-week high the previous day. Trading volume was above average as investors positioned ahead of next week’s earnings and a Federal Reserve meeting. The company’s 1.400% senior notes due 2026 are being delisted from the NYSE. Thermo Fisher reports fourth-quarter results before markets open on Jan. 29.
Kweichow Moutai stock price: 600519 A-shares in focus after Year-of-Horse packaging fix

Kweichow Moutai stock price: 600519 A-shares in focus after Year-of-Horse packaging fix

Kweichow Moutai shares fell 0.23% to 1,337 yuan in Shanghai Friday as investors weighed the company’s response to a packaging error on its “Year of the Horse” limited edition. Moutai resumed production after fixing a misprint and launched an exchange program for affected bottles. A block trade of 2,400 shares at 1,300 yuan drew attention, coming in 2.77% below the close. Broader Chinese markets rose.
24 January 2026
L’Oreal stock price: Barclays turns overweight as Paris investors look to Feb 12 results

L’Oreal stock price: Barclays turns overweight as Paris investors look to Feb 12 results

Barclays upgraded L’Oreal to overweight and raised its target price to 435 euros from 325 euros. L’Oreal shares closed at 386.25 euros on Friday, down 0.26%, with the CAC 40 off 0.07%. Investors are watching for L’Oreal’s 2025 annual results, due after the close on Feb. 12. Barclays cited stronger growth expectations but warned of competition from indie beauty brands.
American Express stock price falls into weekend — what investors watch before AXP earnings

American Express stock price falls into weekend — what investors watch before AXP earnings

American Express shares fell 1.7% to $361.69 Friday as investors reacted to renewed debate over a proposed 10% cap on credit-card interest rates. The stock dragged the Dow lower alongside other financials. American Express reports earnings Jan. 30, with Wall Street expecting $3.53 per share. Bank of America is reportedly considering new cards at the proposed cap rate.
China Construction Bank Class A stock in focus after REITs filing; what to watch next week

China Construction Bank Class A stock in focus after REITs filing; what to watch next week

China Construction Bank’s Shanghai-listed A shares closed down 0.46% at 8.65 yuan Friday after the bank ended a review of its public rental-housing REIT application. The lender said the move would not affect operations. The decision comes as the People’s Bank of China injected 700 billion yuan in liquidity through a medium-term lending facility. Other major state banks also fell despite a rise in the Shanghai Composite.
Applied Materials stock rises on Deutsche Bank upgrade — what investors watch next week

Applied Materials stock rises on Deutsche Bank upgrade — what investors watch next week

Applied Materials closed up 1.13% at $322.38 after Deutsche Bank upgraded the stock to “buy” and raised its price target to $390. The S&P 500 finished nearly flat and the Dow fell 0.58%. Investors await earnings from ASML, Lam Research, and KLA next week, as well as the Federal Reserve’s policy decision. Applied reports results Feb. 12.
Hermes stock price holds near €2,130 — what to watch next for HRMS.PA after a quiet close

Hermes stock price holds near €2,130 — what to watch next for HRMS.PA after a quiet close

Hermes shares closed down 0.05% at 2,130 euros in Paris Friday, tracking a muted CAC 40, with 56,000 shares traded. The STOXX 600 slipped 0.1%, ending a five-week rally as traders watched fallout from Greenland trade tensions. LVMH reports results Jan. 27, followed by the U.S. Fed meeting, both seen as key for luxury stocks. Hermes reports annual results Feb. 12.
24 January 2026
IBM stock price dips into the weekend as investors brace for Jan. 28 earnings

IBM stock price dips into the weekend as investors brace for Jan. 28 earnings

IBM shares fell 0.76% to $292.44 Friday and slipped further after hours ahead of its January 28 earnings report. Investors await fourth-quarter results and guidance, focusing on software and consulting tied to new AI services. IBM Consulting has launched an internal AI delivery platform, but executives warn that scaling real value remains difficult. The company will hold its earnings call Wednesday at 5 p.m. ET.
AstraZeneca stock faces a new test: Iraq terrorism lawsuit revived with NYSE move days away

AstraZeneca stock faces a new test: Iraq terrorism lawsuit revived with NYSE move days away

A U.S. appeals court on Friday revived a lawsuit accusing AstraZeneca and other firms of funding terrorism in Iraq. The ruling was announced after U.S. markets closed; AstraZeneca shares had closed up 1.37% in New York and 0.15% in London. The company plans to switch its U.S. listing from Nasdaq to NYSE on Jan. 30. Investors await Monday’s market reaction.
Morgan Stanley stock slides into weekend as Fed decision, SpaceX IPO talk loom

Morgan Stanley stock slides into weekend as Fed decision, SpaceX IPO talk loom

Morgan Stanley shares fell 2.2% to $179 Friday, underperforming major indexes as bank stocks broadly declined. Goldman Sachs dropped 3.7%, JPMorgan Chase nearly 2%, and Bank of America 1.4%. The S&P 500 was flat, while the Dow lost 0.58%. Investors await the Federal Reserve’s Jan. 28 decision and earnings from Apple, Microsoft, Meta, and Tesla next week.
Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B shares closed up 1.17% at 401.35 crowns in Copenhagen, lifted by strong early U.S. demand for its new Wegovy pill. The company faces a new U.S. lawsuit alleging a “pay-for-delay” scheme for Victoza. Over 18,000 Wegovy pill prescriptions were reported in the U.S. since its Jan. 5 launch. Indian regulators approved local firms to make generic semaglutide ahead of the 2026 patent expiry.
1 122 123 124 125 126 606

Stock Market Today

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop